Frequently Asked Questions

Organic Pharmaceuticals Pvt. Ltd. is a WHO-GMP and ISO 9001:2015 certified pharmaceutical company based in Dadri, Uttar Pradesh, India. Founded in 2000, we specialize in manufacturing and marketing high-quality generic medicines across multiple therapeutic segments, and also offer comprehensive third-party and contract manufacturing services to pharma brands across India.

Our manufacturing facility is located at Organic Pharmaceuticals Pvt. Ltd., Near Navin Hospital, Railway Road, Dadri, G.B. Nagar, Uttar Pradesh — 203207. Dadri gives us significant supply chain and cost advantages.

Our offices operate Monday to Saturday, 9:00 AM to 6:00 PM IST. The manufacturing plant operates 24×7 in multiple shifts. For urgent enquiries outside office hours, you may reach us on WhatsApp at +91 88002 06259 and we will respond as soon as possible.

We were founded in 2000 and have been operational for over 26 years. During this period, we have grown from a regional manufacturer to a pan-India pharmaceutical brand, spanning multiple Indian states.

We currently manufacture over 35 pharmaceutical formulations across multiple dosage forms including tablets, capsules, syrups, dry syrups, suspensions, and topical gels. Our portfolio spans 8+ therapeutic segments including anti-infectives, analgesics, paediatrics, hematinics, respiratory, and nutraceuticals. Contact us for a complete product catalogue.

Our products are sold through the standard pharmaceutical supply chain — we supply to distributors and stockists who then supply to retail pharmacies and hospitals. Individual patients can purchase our products at any pharmacy that stocks our range. All prescription-only (Rx) products require a valid prescription from a registered medical practitioner.

Yes, our manufacturing facility is WHO-GMP certified and ISO 9001:2015 certified. All our products are manufactured as per CDSCO-approved formulations and comply with the Indian Pharmacopoeia (IP) and British Pharmacopoeia (BP) standards where applicable. We also hold DCGI approvals for all marketed formulations and GLP certification for our quality control laboratory.

Absolutely. Our in-house R&D team can develop custom formulations from scratch based on your therapeutic requirements. We can also modify existing formulations for improved bioavailability, palatability (e.g., flavoured paediatric syrups), pack sizes, or specific ingredient combinations. All development projects include stability studies and regulatory filing support.

Minimum order quantities vary by dosage form. Typically: Tablets/Capsules — 50,000 units per SKU; Liquid Orals (Syrups) — 5,000 units; Dry Syrups — 5,000 units; Topical Gels — 3,000 units. We understand that startups and smaller brands need flexibility, so please contact us to discuss your specific requirements — we are often able to accommodate lower MOQs for new clients.

Standard lead times from production commencement to dispatch are: Tablets/Capsules — 25-35 days; Liquid Orals — 20-30 days; Dry Syrups — 25-35 days. Lead times may vary depending on raw material availability, batch size, and current production schedule. Your dedicated account manager will provide a precise timeline upon order confirmation.

Yes, our regulatory affairs team provides complete support for product registration with state drug controllers and CDSCO. This includes preparation of Form 44 (new drug manufacturing licence amendment), dossier preparation, stability study reports, and liaison with regulatory authorities. This service is available as an add-on for all manufacturing partners.

Yes, absolutely. We sign a comprehensive Non-Disclosure Agreement (NDA) before any formulation, pricing, or brand-related discussions take place. All client formulations, approved artworks, brand names, and commercial terms are treated with the highest level of confidentiality and are never shared with third parties.

We can manage the entire secondary packaging supply chain including cartons, labels, inserts, and blister/strip foil. If you have an approved artwork file (in AI, CDR, or PDF format), we can directly use it for printing. If you need artwork created or revised, we can connect you with our empanelled pharmaceutical design agencies. All artwork undergoes mandatory regulatory review before printing.

We are actively expanding our distribution network across India. To become an authorized distributor or stockist, please contact our sales team at info@organic-pharmaceuticals.com or call +91 88002 06259. Requirements include a valid drug licence, GST registration, and the ability to maintain adequate storage conditions as per Drug & Cosmetics Act. Our regional sales manager will guide you through the onboarding process.

Yes, we offer credit facilities to established distributors based on track record and creditworthiness evaluation. New distributors typically start with advance payment for the first 2-3 orders, after which credit terms are evaluated. Please discuss your specific requirements with our sales team during the onboarding process.

We take product quality and patient safety extremely seriously. To report an adverse drug reaction or quality complaint, please contact our pharmacovigilance team at info@organic-pharmaceuticals.com or call our quality hotline at +91 88002 06259. Please preserve the product batch number and pack for investigation purposes. We aim to acknowledge all complaints within 24 hours and resolve them within 30 days as per our quality policy.

We hold the following certifications and approvals: WHO-GMP (Good Manufacturing Practice), ISO 9001:2015 Quality Management System, DCGI (Drug Controller General of India) approved formulations, GLP (Good Laboratory Practice) for our QC laboratory, Ayush Manufacturing Licence for herbal products, compliance with Schedule M of Drugs & Cosmetics Act 1945. Copies of certificates are provided to manufacturing partners upon request.

Yes, every finished goods batch dispatched from our facility is accompanied by a Certificate of Analysis (CoA) and Certificate of Compliance (CoC), both signed by our Head of Quality Assurance. The CoA includes all relevant analytical test results demonstrating compliance with the approved finished product specification.

All Batch Manufacturing Records (BMR), Batch Packing Records (BPR), and Quality Control records are retained for a minimum of 1 year beyond the expiry date of the product batch, or a minimum of 5 years from the date of manufacture, whichever is longer — in compliance with CDSCO and WHO-GMP requirements.

Yes, we conduct comprehensive stability studies as per ICH Q1A(R2) guidelines in our stability chambers (25°C/60% RH and 40°C/75% RH). Accelerated stability studies (6 months) and real-time studies as required by CDSCO are conducted for all new formulations. Stability data is provided to manufacturing partners and is essential for regulatory filings.